Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
The Journal of Investigative Dermatology|January 19, 2005
Lack of evidence for genetic association to RUNX1 binding site at PSORS2 in different German psoriasis cohortsUlrike Hüffmeier, Heiko Traupe, Harald Burkhardt, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2024
Human MHC Class II and Invariant Chain Knock-in Mice Mimic Rheumatoid Arthritis with Allele Restriction in Immune Response and Arthritis AssociationLaura Romero-Castillo, Taotao Li, Nhu-Nguyen Do, et al.BMC Medical Genetics|August 25, 2017
Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patientsSteffen Uebe, Maria Ehrlicher, Arif Bülent Ekici, et al.The Lancet. Rheumatology|January 22, 2024
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trialMichaela Koehm, Tanja Rossmanith, Ann C Foldenauer, et al.JCI Insight|July 7, 2017
Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilageChangrong Ge, Dongmei Tong, Bibo Liang, et al.Journal of Clinical Medicine|December 23, 2022
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)Michaela Koehm, Ann C Foldenauer, Tanja Rossmanith, et al.Annals of the Rheumatic Diseases|August 6, 2018
High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosusLea Winau, Rocio Hinojar Baydes, Axel Braner, et al.Rheumatology (Oxford, England)|March 19, 2021
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)Frank Behrens, Michaela Koehm, Tanja Rossmanith, et al.Plos One|May 29, 2019
New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II studyMatthias Englbrecht, Rieke Alten, Martin Aringer, et al.Cell Reports|April 18, 2019
IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T CellsYingying Han, Javier Mora, Arnaud Huard, et al.Pageof 10